Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pfenex raises $40.5 million in follow-on

Pfenex Inc. (NYSE-M:PFNX) raised $40.5 million through the sale of 2.6 million shares

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE